Literature DB >> 30968641

Glycogen storage disease type 0 due to a novel frameshift mutation in glycogen synthase 2 (GYS2) gene in a child presenting with fasting hypoglycemia and postprandial hyperglycemia.

Bülent Hacıhamdioğlu1, Gamze Özgürhan2, Bahar Çaran2, Evrim Meydan-Aksanlı2, Ece Keskin3.   

Abstract

Hacıhamdioğlu B, Özgürhan G, Çaran B, Meydan-Aksanlı E, Keskin E. Glycogen storage disease type 0 due to a novel frameshift mutation in glycogen synthase 2 (GYS2) gene in a child presenting with fasting hypoglycemia and postprandial hyperglycemia. Turk J Pediatr 2018; 60: 581-583. Glycogen storage disease type 0 (GSD0) has been considered a rare disorder, it is characterized with ketotic hypoglycemia after prolonged fasting and postprandial hyperglycemia. Herein, we report a novel mutation in the glycogen synthase 2 gene in a Turkish child, as well as her clinical characteristics and 12-month follow-up. We evaluated a 5-year-old girl for asymptomatic fasting ketotic hypoglycemia with postprandial hyperglycemia diagnosed with glycogen storage disease type 0. We identified a novel frameshift mutation, c.1081delA (p.Thr361Glnfs*2) in exon 8 on glycogen synthase 2 gene. Children with GSD0 may have a mild phenotype and GSD0 may be underdiagnosed due to subclinical or asymptomatic hypoglycemia. The diagnosis of GSD0 should be considered in a child with ketotic fasting hypoglycemia with postprandial hyperglycemia but without hepatomegaly.

Entities:  

Keywords:  glycogen storage disease type 0; glycogen synthase 2 gene; ketotic hypoglycemia

Mesh:

Substances:

Year:  2018        PMID: 30968641     DOI: 10.24953/turkjped.2018.05.018

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  3 in total

1.  Novel GYS2 mutations in a Japanese patient with glycogen storage disease type 0a.

Authors:  Hiroyuki Iijima; Yasuhiko Ago; Ryoji Fujiki; Takaaki Takayanagi; Mitsuru Kubota
Journal:  Mol Genet Metab Rep       Date:  2021-01-10

2.  Value of glycogen synthase 2 in intrahepatic cholangiocarcinoma prognosis assessment and its influence on the activity of cancer cells.

Authors:  Sigen A; Huijun Wu; Xiaodong Wang; Xidong Wang; Jiarui Yang; Long Xia; Yijun Xia
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 3.  A patient with glycogen storage disease type 0 and a novel sequence variant in GYS2: a case report and literature review.

Authors:  Janez Jan Arko; Marusa Debeljak; Mojca Zerjav Tansek; Tadej Battelino; Urh Groselj
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.